If your email program has trouble displaying this email, view as a webpage. FDA Requests Comment on Eligibility for Indexing of Unapproved Animal Drugs The U.S. Food and Drug Administration is requesting comments on the agency's current policy for determining the eligibility of unapproved animal drugs to be added to the Index of Legally Marketed Unapproved New Animal Drugs for Minor Species (the Index). The Index is one incentive established by the Minor Use and Minor Species Animal Health Act of 2004 (the MUMS Act), which was enacted to encourage the development of animal drugs that are unavailable to minor species (species other than cattle, horses, swine, chickens, turkeys, dogs, and cats) or to major species afflicted with uncommon diseases or conditions (minor use), while still ensuring appropriate safeguards for animal and human health. You are subscribed to updates from FDA's Center for Veterinary Medicine.

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA